Domov › Vysoký krvný tlak › Arizona
Klinické štúdie Vysoký krvný tlak v štáte Arizona
12 štúdií pre Vysoký krvný tlak hľadá účastníkov v zariadeniach v štáte Arizona.
Mestá v štáte Arizona
Oficiálny text štúdie (anglicky)
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Tucson
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07142356A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Banner - University Medical Center Tucson, Tucson
Prebieha nábor
Vek 18 až 85 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07214376A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Arizona Clinical Trials - Chandler, Chandler
- Elite Clinical Studies, Phoenix
- Clinical Research Institute of Arizona, LLC, Sun City West
- a 3 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Care Access - 801 South Power Road, Mesa, Mesa
- Absolute Clinical Research, Phoenix
- Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Surprise
- Research Site, Tucson
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- HonorHealth, Scottsdale
Prebieha nábor
Vek 22 až 75 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06559891Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Chandler
- Clinical Trial Site, Gilbert
- Clinical Trial Site, Mesa
- a 8 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT07181109Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
- Banner University Medical Center South, Tucson
- UAHS Center for Sleep, Circadian, & Neuroscience Research Department of Medicine, University of Arizona, Tucson
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07799961Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Phoenix
- Vanda Investigative Site, Tempe
- Vanda Investigative Site, Tucson
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 27. 2. 2026 · NCT07090161bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
- University of Arizona, Tucson
Prebieha nábor
Vek 60 a viac · Všetky pohlavia · Aktualizované 15. 10. 2025 · NCT06307574CardioCare Quest: A Co-created Game for Improving Hypertension Treatment Compliance in Arizona
- School of Informatics Computing and Cyber Systems, Flagstaff
- Northern Arizona University, Flagstaff
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 6. 2025 · NCT06487637Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.